ALC Alcondata gap · 92% coverage
Health Care · Ophthalmic Goods · close $66.18 (2026-10-16) · latest quarter in EDGAR: 2010-12-31
Alcon (ALC) has a ThetaGrade House Rating of 72/100 (grade B), ranking #95 of 150 in Health Care. Its strongest pillars are cash flow (94) and valuation (89); its weakest is growth (44). Data gap: 2 factors without usable data, so 92% of the method weight is covered. TTM revenue growth is 10.5% and operating margin 34.5%.
Data as of .
Data gap
No usable data for: Consensus score (1–5), 90-day net rating shift. Data gap: no usable data for this factor, so it is left out and its weight is shared among the factors that do have data (no value is imputed). 92% of the full method weight is backed by data.
Analyst sentiment
weight 7.5% · no data · —| Consensus score (1–5) (0.0%)data gap | derived | — |
| 90-day net rating shift (0.0%)data gap | derived | — |
Growth
weight 30.83% (→33.3%) · 44| Revenue growth YoY (TTM) (13.3%) | 10.5% | 54 |
| EPS growth YoY (TTM) (13.3%) | 9.1% | 43 |
| Revenue acceleration (6.7%) | -3.4% | 25 |
Profitability
weight 18.5% (→20.0%) · 85| Operating margin (10.7%) | 34.5% | 92 |
| 4Q gross-margin change (9.3%) | 1.5% | 76 |
Balance sheet
weight 18.5% (→20.0%) · 81| Net debt / EBITDA (10.7%) | -0.92× | 83 |
| Current ratio (5.3%) | 3.39 | 64 |
| Interest coverage (4.0%) | 275.00× | 97 |
Cash flow
weight 12.33% (→13.3%) · 94| FCF margin (6.7%) | 28.8% | 91 |
| FCF yield (6.7%) | 10.3% | 97 |
Valuation
weight 12.33% (→13.3%) · 89| P/E (inverted) (6.7%) | 9.09× | 99 |
| EV/Sales (inverted) (6.7%) | 2.44× | 79 |
Technicals (EOD)
| RSI(14) | 53.0 |
| EMA 9 / 21 | 64.75 / 65.14 |
| 200-day SMA | 72.48 |
| Volume vs 20d avg | 0.79× |
| 20-day return | 1.5% |
Exit-rule monitor
- WATCHTrend: close below 200-day average
Data source per metric (SEC XBRL tag or derivation): Revenue: SalesRevenueNet · Gross profit: GrossProfit · Operating income: OperatingIncomeLoss · Interest expense: InterestExpense · D&A: Depreciation · EPS: EarningsPerShareDiluted · Market cap: SEC shares (us-gaap CommonStockSharesOutstanding (balance sheet)) × EOD close · P/E: EOD close ÷ SEC TTM EPS (EarningsPerShareDiluted).
Get rating changes like ALC's in the free Daily Brief
The market’s key events and signals, digested before the open.
- ✓ Pre-market Daily Brief: events, headlines, rating changes (2-min read)
- ✓ Sunday: Top 5 Weekly Picks, exit alerts, CSP put watchlist
- ✓ OPEX, FOMC, CPI and jobs-day reminders
Free. Want more? See Premium (waitlist).
FAQ
- What is ALC's House Rating?
- ALC scores 72 out of 100 (grade B) as of 2026-10-16, ranking #95 of 150 Health Care stocks we cover.
- What do analysts say about ALC?
- We do not have enough analyst-sentiment data to score this stock.
- When does ALC report earnings next?
- We could not estimate ALC's next earnings date from SEC filings. Check the company's investor-relations page.
- Is ALC a buy?
- ThetaGrade does not give personal advice. The House Rating is an educational, rules-based summary of public data; see the methodology for how it is built.
Sources: SEC EDGAR filings (fetched 2026-10-18), Finnhub recommendation trends, Massive EOD prices. Scores are sector percentiles; a factor without usable data is a data gap: it is left out and the remaining weights are renormalized (nothing is imputed). Educational only. Methodology